YTD lows…Competition is in shambles... not a peep from Sernova. Endless hints at deal(s) continues to not materialize. "Imminent" TSX listing continues to be elusive. Unable to convince institutionals to invest. Share price at YTD lows.
yep... the clinical studies, applications and science seems ok. In fact the only consistent value add to this company is Piotr Witowski.
all other attempts for the SP to break out were based on expectations of business deal (expectations created by PT). And every deception was accompanied by SP decline.
including this time. PT did go to Europe. Doesn't mean he came home with a signed piece of paper.
Does anyone still think this management team is competent?